findmyKOL

John Herre, MD

Enriched profile

Medical Director, Advanced Heart Failure Program; Medical Director, Cardiology Division, Sentara Clinical Research · Sentara Norfolk General Hospital

ORCIDNPI
Region🇺🇸 Chesapeake, VA · Southeast · United StatesSpecialtyAdvanced Heart Failure and Transplant CardiologyFocusHeart Failure
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2021Online presenceverified 2026Payments2021–2025NIH fundingNone on fileWhy? →

John Herre is Medical Director, Advanced Heart Failure Program; Medical Director, Cardiology Division, Sentara Clinical Research at Sentara Norfolk General Hospital. OpenAlex indexes 160 publications with 6,131 citations (h-index 39); ClinicalTrials.gov lists 1 registered study with this person as an investigator.

Data verified 14 Aug 2026

Overview

Updated 27 Aug 2026

John M. Herre, MD, is Medical Director, Advanced Heart Failure Program at Sentara Norfolk General Hospital / Sentara Healthcare. The public record shows 160 publications with 6,131 citations (h-index 39), centered on Heart Failure. It also documents an investigator role on 1 registered clinical trials, industry payments reported by 6 companies.

  • Most recent indexed publication: 2021 · ASAIO journal (American Society for Artificial Internal Organs
  • Top research focus: Heart Failure
  • 1 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 6 companies

Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Heart Failure1 trial

Research focus

OpenAlex concept fingerprint
Heart Failure

Drugs & molecules

across trials, industry payments and publications
Farxigageneric · DapagliflozinClinical trialsIndustry payments1PublicationsPerflutrenClinical trialsIndustry payments1Publications

Works with

trial sponsors and companies reporting payments
LifeNet HealthClinical trialsIndustry payments40AbiomedClinical trialsIndustry payments9Abbott LaboratoriesClinical trialsIndustry payments2

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
160publications

Distinct works indexed by OpenAlex, matched via ORCID; 1 in PubMed.

6,131citations

Total citations across indexed works.

39h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
1clinical trials

Investigator role on registered studies.

View trials
6companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments
0NIH grants

Federally funded research awards.

Public positions

sourced statements on record
  • Chairman

    Board of Directors, LifeNet Health (organ procurement organization)

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →sentara.com

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 27 Aug 2026

Listed as an investigator on 1 registered study on ClinicalTrials.gov. The most recent:

Industry payments

Updated 27 Aug 2026

6 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    63.6%
    Beta blocker12.1%
    Carvedilol57%Metoprolol Succinate37%Metoprolol Tartrate5%Sotalol2%
    Part D<11 patients
    Statin8.7%
    Atorvastatin Calcium64%Rosuvastatin Calcium21%Pravastatin Sodium11%Simvastatin4%
    Part D<11 patients
  • Metabolism & gastrointestinal

    19.1%
    SGLT2 inhibitor11.7%
    Farxiga60%Jardiance37%Dapagliflozin3%
    Part D112 patients
    Proton pump inhibitor3%
    Omeprazole76%Pantoprazole Sodium24%
    Part D40 patients
  • Blood & clotting

    6.7%
    Factor Xa inhibitor3.3%
    Eliquis82%Xarelto18%
    Part D50 patients
    Vitamin K antagonist2.1%
    Warfarin Sodium100%
    Part D39 patients
7 more therapeutic areas behind the reveal.Reveal →
Where care is delivered (Part B)86.7% facility · 13.3% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →

Publications

Updated 27 Aug 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Online presence

Updated 27 Aug 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Doximity

    doximity.com/pub/john-herre-md

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com

Mentions by others

where others cite or feature them
  • YouTube

    youtube.com/watch

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 27 Aug 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record

Editorial & leadership roles

journal and society appointments
  • Fellow

    American College of Cardiology (F.A.C.C.)

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →sentara.com
  • Fellow

    American College of Physicians (F.A.C.P.)

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →sentara.com
  • Member

    Heart Failure Society of America; American College of Cardiology; International Society of Heart and Lung Transplantation

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →sentara.com
1 more role behind the reveal.Reveal →

Awards & honors

honors on the public record

Secondary affiliations

appointments beyond the home institution

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.